Improving the Effects of Imeglimin on Endothelial Function: A Prospective, Single-Center, Observational Study

Introduction Endothelial dysfunction is a risk factor for cardiovascular disease in patients with diabetes. We hypothesized that imeglimin, a novel oral hypoglycemic agent, would improve endothelial function. Methods In this study, imeglimin was administered to patients with type 2 diabetes and HbA1...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes therapy 2023-03, Vol.14 (3), p.569-579
Hauptverfasser:	Uchida, Taisuke, Ueno, Hiroaki, Konagata, Ayaka, Taniguchi, Norifumi, Kogo, Fumiko, Nagatomo, Yuma, Shimizu, Koichiro, Yamaguchi, Hideki, Shimoda, Kazuya
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Diabetes Dosage and administration Drug therapy Endocrinology Endothelium Glucose Health aspects Hypoglycemia Hypoglycemic agents Insulin Internal Medicine Medicine Medicine & Public Health Observational studies Original Research Testing Type 2 diabetes UMIN UMIN000046311
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!